Frank Barone Funding: How Much Did They Raise & Key Investors

How Much Did Frank Barone Raise?
Funding & Key Investors

EVOLV Medical Aesthetics has successfully secured a significant capital injection, bringing its total funding to $150K. This latest infusion of $150K represents a major strategic investment, underscoring the firm's robust trajectory within the competitive medical aesthetics landscape. By leveraging this financial backing, the organization is well-positioned to solidify its market presence and expand its operational footprint in the specialized healthcare sector.

The recent financing round highlights investor confidence in the company's ability to scale its high-demand service offerings. As the aesthetic medicine industry continues to experience rapid growth, this capital provides the necessary liquidity to enhance service delivery and maintain the high standards of clinical excellence that define the EVOLV brand.

What is Frank Barone?

Frank Barone

Hospitals & Physicians Clinics

Physicians Clinics

Medical Practice Management

EVOLV Medical Aesthetics operates as a premier provider of comprehensive plastic surgery and non-surgical aesthetic treatments based in Toledo. The company distinguishes itself through a patient-centric model that integrates advanced surgical procedures with body sculpting and specialized skincare solutions. By prioritizing personalized treatment plans, EVOLV addresses a diverse demographic, effectively bridging the gap between clinical medical care and elective aesthetic enhancement. Their commitment to confidentiality and professional oversight has established them as a trusted authority in the regional healthcare market, consistently delivering measurable results for a growing client base.

How much funding has Frank Barone raised?

Frank Barone has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Frank Barone

PPP

Public-Private Partnership

What's next for Frank Barone?

With the recent influx of capital, EVOLV Medical Aesthetics is poised to enter a new phase of organizational maturity. The strategic focus will likely shift toward scaling its infrastructure to accommodate increased patient volume while potentially exploring new geographic markets. By optimizing its service delivery model and investing in cutting-edge aesthetic technologies, the company aims to reinforce its competitive advantage. This late-stage funding serves as a catalyst for long-term sustainability, enabling the firm to refine its operational efficiencies and continue its trajectory as a leader in the medical aesthetics space.

See full Frank Barone company page

See More Financial Insights